BioCentury
ARTICLE | Company News

InterMune Life deal

February 28, 1994 8:00 AM UTC

INLI (Toronto) entered into an agreement with Biological Research Institute of the National Research Council of Canada to develop Profertyn (PP14), INLI's in vitro fertilization enhancer. Since PP14 i...